CIK: 1451330 - Address: Ostergade 24A, 1, Dk-1100, Copenhagen K, G7
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret116-3-4-42373310
S%wins50835067171747

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/15/14 17:24
7/11/14
QLTIQlt Inc/bcA1HealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-5,8005.802-1,000-136,448D51411101418-24-3-6-15-35-27-32
9/1/11 19:42
8/30/11
QLTIQlt Inc/bcA1HealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS.m-9447.262-130-27,398D73254-66191812-2-21-524
8/31/11 19:31
8/29/11
QLTIQlt Inc/bcA1HealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-1,4177.083-200-37,528D69266-452417171-2-1-674
4/26/10 17:24
4/26/10
SUPGSupergen IncDEHealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-3573.110-115-26,021D
4/26/10 17:23
4/22/10
SUPGSupergen IncDEHealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS.m-8443.130-269-46,136D
4/26/10 17:22
4/22/10
SUPGSupergen IncDEHealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-9273.260-285-46,405D
10/23/09 15:44
10/21/09
QLTIQlt Inc/bcA1HealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-6,4003.202-2,000-227,257D-21377415-19-10-7-122-17348460
10/21/09 17:57
10/19/09
QLTIQlt Inc/bcA1HealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-1,0463.972-264-39,257D-24307835-17-3-6-112311368462
2/12/09 16:25
2/11/09
QLTIQlt Inc/bcA1HealthDrugPharmaceutical PreparationsNb Public Equity K/sG7TS-522.321-2206,918-15-18-25-1174102

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact